Immunovia AB (publ) (IMMNOV.ST)
SEK 0.66
(1.23%)
SEK 0.66
(1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.57 Million | 1.14 Million | 844 Thousand | 362 Thousand | 356 Thousand | 332.59 Thousand |
| Cost of Revenue | 6.68 Million | 4.21 Million | -14.96 Million | -40.02 Million | -26.71 Million | -25.05 Million |
| Gross Profit | -5.1 Million | -3.06 Million | 15.81 Million | 40.38 Million | 27.07 Million | 25.38 Million |
| Operating Expenses | 291.35 Million | 188.14 Million | 182.55 Million | 175.06 Million | 141.42 Million | 113.83 Million |
| Selling, General and Administrative Expenses | 148.3 Million | -47.9 Million | 82.6 Million | 91.14 Million | 78.32 Million | 65.27 Million |
| Research and Development Expenses | 28.2 Million | 47.9 Million | 43 Million | 48.1 Million | 34.2 Million | 26.04 Million |
| Other Expenses | 114.84 Million | 188.14 Million | 99.94 Million | 83.91 Million | 63.1 Million | 221.22 Thousand |
| Cost and Expenses | 298.03 Million | 192.35 Million | 167.58 Million | 135.04 Million | 114.7 Million | 88.78 Million |
| Operating Income | -296.46 Million | -191.15 Million | -166.74 Million | -134.67 Million | -114.35 Million | -87.7 Million |
| Interest Expense | 1.16 Million | 1.6 Million | 1.43 Million | 1.41 Million | 1.31 Million | 697.00 |
| Income Tax Expense | - | -23.05 Million | 1.43 Million | 1.41 Million | 4000.00 | 7345.00 |
| Earnings before Tax | -309.43 Million | -168.09 Million | -155.96 Million | -146.03 Million | -114.51 Million | -86.53 Million |
| Net Income | -309.43 Million | -145.03 Million | -157.39 Million | -147.45 Million | -114.52 Million | -86.53 Million |
| Earnings Per Share Basic | -7.38 | -5.95 | -6.45 | -6.41 | -5.43 | -4.33 |
| Earnings Per Share Diluted | -7.38 | -5.95 | -6.45 | -6.41 | -5.43 | -4.33 |
| Weighted Average Shares Outstanding | 41.94 Million | 24.38 Million | 24.38 Million | 22.99 Million | 21.08 Million | 19.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.94 Million | 24.38 Million | 24.38 Million | 22.99 Million | 21.08 Million | 19.98 Million |
| Gross Margin | -3.24 | -2.68 | 18.74 | 111.55 | 76.04 | 76.32 |
| EBIT Margin | -105.75 | -123.65 | -160.51 | -372.52 | -294.25 | -251.82 |
| Profit Margin | -196.47 | -126.67 | -186.49 | -407.32 | -321.69 | -260.19 |
| EBITDA | -166.55 Million | -141.57 Million | -135.47 Million | -134.85 Million | -104.75 Million | -83.75 Million |
| Earnings Before Tax Margin | -188.23 | -166.94 | -197.56 | -372.04 | -321.21 | -263.71 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 85 Thousand | 156 Thousand | 1.57 Million | 156 Thousand | 488 Thousand | 412 Thousand |
| Cost of Revenue | 24.05 Million | - | 6.68 Million | 22.47 Million | 144 Thousand | 5.5 Million |
| Gross Profit | -23.97 Million | 156 Thousand | -5.1 Million | -22.31 Million | 344 Thousand | -5.08 Million |
| Operating Expenses | 23.99 Million | 24.31 Million | 291.5 Million | 23.71 Million | 39.23 Million | 179.99 Million |
| Selling, General and Administrative Expenses | -5.31 Million | 21.74 Million | - | 20.03 Million | -6.71 Million | -8.24 Million |
| Research and Development Expenses | 5.31 Million | 6.55 Million | - | 4.09 Million | 6.71 Million | 8.24 Million |
| Other Expenses | -3.78 Million | - | -310.99 Million | -49.15 Million | - | - |
| Cost and Expenses | 24.05 Million | 24.31 Million | 298.19 Million | 23.71 Million | 39.37 Million | 185.49 Million |
| Operating Income | -23.97 Million | -24.15 Million | -296.46 Million | -23.4 Million | -38.88 Million | -185.07 Million |
| Interest Expense | 1.69 Million | 147 Thousand | 1.16 Million | -3.12 Million | 635 Thousand | 647 Thousand |
| Income Tax Expense | - | 21.35 Million | 309.41 Million | 49 Million | 968 Thousand | 15.51 Million |
| Earnings before Tax | -25.59 Million | -2.94 Million | -309.43 Million | -49.02 Million | -38.55 Million | -170.2 Million |
| Net Income | -25.59 Million | -2.94 Million | -309.43 Million | -49.02 Million | -38.55 Million | -170.2 Million |
| Earnings Per Share Basic | -0.28 | -0.07 | - | -1.08 | -0.91 | -4.00 |
| Earnings Per Share Diluted | -0.28 | -0.07 | - | -1.08 | -0.91 | -4.00 |
| Weighted Average Shares Outstanding | 91.16 Million | 45.28 Million | 41.94 Million | 45.28 Million | 42.51 Million | 42.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.16 Million | 45.28 Million | 41.94 Million | 45.28 Million | 42.51 Million | 42.51 Million |
| Gross Margin | -282.04 | 1.00 | -3.24 | -143.05 | 0.70 | -12.35 |
| EBIT Margin | -263.25 | 1.16 | - | -318.65 | -72.59 | -94.29 |
| Profit Margin | -301.14 | -18.88 | -196.47 | -314.23 | -79.01 | -413.12 |
| EBITDA | -22.37 Million | 181 Thousand | - | -49.71 Million | -35.42 Million | -38.84 Million |
| Earnings Before Tax Margin | -282.04 | -154.85 | -188.23 | -150.04 | -79.69 | -449.21 |
8111
0HYA
INNOVTEC
GNC
3535
0HFR